Healthcare Sales & Marketing Network News: hydralazine

Searching News Database: hydralazine

HSMN NewsFeed - 23 Oct 2008
NitroMed Announces Agreement to Sell BiDil(R) Drug Business to JHP Pharmaceuticals, LLC
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 16 Jun 2008
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Heritage Announces $10 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jan 2008
NitroMed Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options
Biopharmaceuticals

HSMN NewsFeed - 25 Mar 2007
EVEREST Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
Biopharmaceuticals Cardiology

HSMN NewsFeed - 6 Mar 2007
Michael L. Sabolinski, M.D. Resigns from NitroMed
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2007
Kenneth M. Bate Named CEO of NitroMed
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2006
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 May 2006
FDA Confirms No Drugs are Therapeutically Equivalent to BiDil(R)
Biopharmaceuticals Cardiology Generics FDA

Return to NewsFeed

Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 24 additional stories matching:
hydralazine
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.